Liminatus Pharma, Inc. Warrants
Liminatus Pharma, Inc. operates as a pre-clinical stage biopharmaceutical company that develops novel cancer therapies. It is developing CD47, a high affinity humanized anti CD47 antibody that has the potential to translate into clinic for CD47 SIRPa blocking and restoring the anti-tumor function of innate immune cells without inducing hemagglutination or hemolysis. The company was founded in 201… Read more
Market Cap & Net Worth: Liminatus Pharma, Inc. Warrants (LIMNW)
Liminatus Pharma, Inc. Warrants (NASDAQ:LIMNW) has a market capitalization of $559.56 ($559.56) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #48761 globally and #14980 in its home market, demonstrating a -29.41% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Liminatus Pharma, Inc. Warrants's stock price $0.06 by its total outstanding shares 9326 (9.33K).
Liminatus Pharma, Inc. Warrants Market Cap History: 2025 to 2026
Liminatus Pharma, Inc. Warrants's market capitalization history from 2025 to 2026. Data shows growth from $326.41 to $559.56 (0.00% CAGR).
Liminatus Pharma, Inc. Warrants Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Liminatus Pharma, Inc. Warrants's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of LIMNW by Market Capitalization
Companies near Liminatus Pharma, Inc. Warrants in the global market cap rankings as of March 18, 2026.
Key companies related to Liminatus Pharma, Inc. Warrants by market ranking:
- China Dasheng Biotechnology Company (PINK:CDBT): Ranked #48752 globally with a market cap of $562.56 USD.
- Trakm8 Holdings PLC (LSE:TRAK): Ranked #48753 globally with a market cap of $562.45 USD ( GBX4.62 Million GBX).
- Sassy Gold Corp. (OTCQB:SSYRD): Ranked #48762 globally with a market cap of $554.43 USD.
- CENTRAL PETROLEUM (C9J.SG) (STU:C9J): Ranked #48763 globally with a market cap of $553.96 USD ( €539.68 EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #48752 | China Dasheng Biotechnology Company | PINK:CDBT | $562.56 | $0.06 |
| #48753 | Trakm8 Holdings PLC | LSE:TRAK | $562.45 | GBX9.25 |
| #48762 | Sassy Gold Corp. | OTCQB:SSYRD | $554.43 | $0.06 |
| #48763 | CENTRAL PETROLEUM (C9J.SG) | STU:C9J | $553.96 | €0.05 |
Liminatus Pharma, Inc. Warrants Historical Marketcap From 2025 to 2026
Between 2025 and today, Liminatus Pharma, Inc. Warrants's market cap moved from $326.41 to $ 559.56, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $559.56 | +71.43% |
| 2025 | $326.41 | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Liminatus Pharma, Inc. Warrants was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $559.56 USD |
| MoneyControl | $559.56 USD |
| MarketWatch | $559.56 USD |
| marketcap.company | $559.56 USD |
| Reuters | $559.56 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.